FDA ad­vi­sors ques­tion whether Iterum's ap­pli­ca­tion for a UTI an­tibac­te­r­i­al is re­stric­tive enough

9 months ago
Pharma
FDA+

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

9 months ago
China
Manufacturing

A Gen­er­al Cat­a­lyst-backed start­up raised $38M to help work­ers buy health cov­er­age on their own

9 months ago
Startups
Health Tech

#WCLC24 roundup: Ar­riVent thinks its drug can fill Tagris­so's gaps; Boehringer, Bay­er's da­ta in HER2-mu­tat­ed lung ...

9 months ago
R&D

CDER chief on in­spec­tion back­log: 2025 will be a 'cru­cial year'

9 months ago
FDA+

GSK says long-act­ing asth­ma hope­ful sig­nif­i­cant­ly cut at­tacks

9 months ago
R&D
Pharma

As­traZeneca, Gilead de­tail TROP2 ADC da­ta in lung can­cer as they search for new ways for­ward

9 months ago
R&D

Zealand’s GLP-1/GLP-2 drug bounces back with new Phase 1b da­ta

9 months ago
R&D

#ES­MO24 roundup: New da­ta on Am­gen’s PRMT5 in­hibitor seem lack­lus­ter, and Jazz’s HER2 an­ti­body

9 months ago
R&D

As­traZeneca's mon­o­clon­al an­ti­body miss­es pri­ma­ry end­point in mid-stage tri­al in COPD

9 months ago
R&D

Im­muno­vant shares mid-stage Graves’ dis­ease da­ta; FDA lifts Re­zo­lute’s hold

9 months ago
News Briefing

Bi­cy­cle Ther­a­peu­tics makes an ear­ly case for its Pad­cev com­peti­tor: #ES­MO24

9 months ago
R&D

In­vestors pour $370M+ in­to Ken Song's au­toim­mune biotech af­ter his Rayze­Bio suc­cess

9 months ago
Financing
Startups

Mer­ck, Dai­ichi Sankyo de­tail Phase 2 ADC re­sults in small cell lung can­cer, bis­pe­cif­ic com­bo strat­e­gy

9 months ago
R&D

Lil­ly again hires from with­in for CFO post, el­e­vat­ing 23-year com­pa­ny vet­er­an

9 months ago
People
Pharma

MBX seeks $114M IPO to com­pete with As­cendis and get a long-act­ing GLP-1/GIP pro­drug in­to the clin­ic

9 months ago
Financing
Startups

Re­lay Ther­a­peu­tics re­ports pos­i­tive PFS da­ta for its PI3Kα in­hibitor com­bo in breast can­cer

9 months ago
R&D

Terns’ oral GLP-1 pass­es Phase 1 test with promis­ing weight loss af­ter one month

9 months ago
R&D

Eli Lil­ly in­vests in Su­per­lu­mi­nal's $120M Se­ries A round as AI-fo­cused star­tups eye the clin­ic

9 months ago
Financing
AI

Sum­mit's Phase 3 da­ta back up biotech's boasts of beat­ing Keytru­da in lung can­cer

9 months ago
R&D
China

No­table shake­ups this week; Re­cur­sion's mixed da­ta; Eli Lil­ly's $1B bet; and more

9 months ago
Weekly

Ex­clu­sive: In­flu­en­tial De­mo­c­rat will op­pose Biose­cure Act ahead of House vote

9 months ago
Deals
R&D

Fed­er­al judge re­jects phar­ma in­dus­try’s re­quest to halt Mary­land’s 340B law

9 months ago
Pharma
Law

Non-vi­ral de­liv­ery start­up Vesi­gen Ther­a­peu­tics trims staff as it eval­u­ates 's­trate­gic op­tion­s'

9 months ago
People
Startups
First page Previous page 113114115116117118119 Next page Last page
A service from the Financial Times